DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients

Information source: Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Psoriasis

Intervention: etanercept (Drug)

Phase: N/A

Status: Enrolling by invitation

Sponsored by: Universitaire Ziekenhuizen Leuven

Summary

The purpose of this study is to investigate the association between trough serum levels of etanercept, antibodies towards etanercept and its effectiveness in psoriasis patients.

Clinical Details

Official title: Intermittent Versus Continuous Treatment: an Observational Monocentric Study Investigating the Association Between Trough Levels of Enbrel and Therapy Regimen

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome:

trough serum etanercept concentration

anti-etanercept serum concentration

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age from 18 years on, male or female

- Established diagnosis of psoriasis

- Etanercept either on monotherapy or in combination with acitretin (Neotigason®),

given according to the current EU SmPC including the safety measures.

- Patients who give informed consent for this study

Locations and Contacts

Additional Information

Starting date: January 2015
Last updated: January 8, 2015

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017